APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Automatic Insulin Dose Adjustment Software

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Automatic Insulin Dose Adjustment Software Market Outlook and Growth Opportunities 2026

Report ID 17407302046 March 2026196 pages

Choose your research edition.

Industry ResearchAutomatic Insulin Dose Adjustment Software Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Automatic Insulin Dose Adjustment Software Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Automatic Insulin Dose Adjustment Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Automatic Insulin Dose Adjustment Software Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Automatic Insulin Dose Adjustment Software Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Automatic Insulin Dose Adjustment Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Automatic Insulin Dose Adjustment Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Automatic Insulin Dose Adjustment Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Automatic Insulin Dose Adjustment Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Automatic Insulin Dose Adjustment Software market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Automatic Insulin Dose Adjustment Software market include Glytec, Beta Bionics, Hygieia, Tandem Diabetics, CamDiab, Medtronic, Novo Nordisk, Omnipod and Tempo Platform, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Automatic Insulin Dose Adjustment Software market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Automatic Insulin Dose Adjustment Software and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Automatic Insulin Dose Adjustment Software revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Automatic Insulin Dose Adjustment Software market.

Automatic Insulin Dose Adjustment Software Segment by Company

Glytec

Beta Bionics

Hygieia

Tandem Diabetics

CamDiab

Medtronic

Novo Nordisk

Omnipod

Tempo Platform

Automatic Insulin Dose Adjustment Software Segment by Type

Open-Loop Systems

Closed-Loop Systems

Automatic Insulin Dose Adjustment Software Segment by Application

Subscription Used

One-time Purchase Used

Automatic Insulin Dose Adjustment Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Automatic Insulin Dose Adjustment Software status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Automatic Insulin Dose Adjustment Software key companies, revenue, market share, and recent developments.

3. To split the Automatic Insulin Dose Adjustment Software breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Automatic Insulin Dose Adjustment Software market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Automatic Insulin Dose Adjustment Software significant trends, drivers, influence factors in global and regions.

6. To analyze Automatic Insulin Dose Adjustment Software competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Automatic Insulin Dose Adjustment Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Automatic Insulin Dose Adjustment Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Automatic Insulin Dose Adjustment Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Automatic Insulin Dose Adjustment Software industry.

Chapter 3: Detailed analysis of Automatic Insulin Dose Adjustment Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Automatic Insulin Dose Adjustment Software in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Automatic Insulin Dose Adjustment Software in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Automatic Insulin Dose Adjustment Software Industry Trends Table 2. Automatic Insulin Dose Adjustment Software Industry Drivers Table 3. Automatic Insulin Dose Adjustment Software Industry Opportunities and Challenges Table 4. Automatic Insulin Dose Adjustment Software Industry Restraints Table 5. Global Automatic Insulin Dose Adjustment Software Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Automatic Insulin Dose Adjustment Software Revenue Share by Company (2021-2026) Table 7. Global Automatic Insulin Dose Adjustment Software Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Automatic Insulin Dose Adjustment Software Key Company Manufacturing Base & Headquarters Table 9. Global Automatic Insulin Dose Adjustment Software Company, Product Type & Application Table 10. Global Automatic Insulin Dose Adjustment Software Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Automatic Insulin Dose Adjustment Software by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Open-Loop Systems Table 15. Significant Companies of Closed-Loop Systems Table 16. Global Automatic Insulin Dose Adjustment Software Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Automatic Insulin Dose Adjustment Software Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Automatic Insulin Dose Adjustment Software Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Automatic Insulin Dose Adjustment Software Sales Value Share by Type (2021-2026) Table 20. Global Automatic Insulin Dose Adjustment Software Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Subscription Used Table 22. Significant Companies of One-time Purchase Used Table 23. Global Automatic Insulin Dose Adjustment Software Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Automatic Insulin Dose Adjustment Software Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global Automatic Insulin Dose Adjustment Software Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global Automatic Insulin Dose Adjustment Software Sales Value Share by Application (2021-2026) Table 27. Global Automatic Insulin Dose Adjustment Software Sales Value Share by Application (2027-2032) Table 28. Global Automatic Insulin Dose Adjustment Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Automatic Insulin Dose Adjustment Software Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global Automatic Insulin Dose Adjustment Software Sales Value Share by Region (2021-2026) Table 31. Global Automatic Insulin Dose Adjustment Software Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global Automatic Insulin Dose Adjustment Software Sales Value Share by Region (2027-2032) Table 33. Global Automatic Insulin Dose Adjustment Software Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Automatic Insulin Dose Adjustment Software Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global Automatic Insulin Dose Adjustment Software Sales Value Market Share by Country (2021-2026) Table 36. Global Automatic Insulin Dose Adjustment Software Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global Automatic Insulin Dose Adjustment Software Sales Value Market Share by Country (2027-2032) Table 38. Glytec Company Information Table 39. Glytec Business Overview Table 40. Glytec Automatic Insulin Dose Adjustment Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. Glytec Automatic Insulin Dose Adjustment Software Product Portfolio Table 42. Glytec Recent Development Table 43. Beta Bionics Company Information Table 44. Beta Bionics Business Overview Table 45. Beta Bionics Automatic Insulin Dose Adjustment Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Beta Bionics Automatic Insulin Dose Adjustment Software Product Portfolio Table 47. Beta Bionics Recent Development Table 48. Hygieia Company Information Table 49. Hygieia Business Overview Table 50. Hygieia Automatic Insulin Dose Adjustment Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Hygieia Automatic Insulin Dose Adjustment Software Product Portfolio Table 52. Hygieia Recent Development Table 53. Tandem Diabetics Company Information Table 54. Tandem Diabetics Business Overview Table 55. Tandem Diabetics Automatic Insulin Dose Adjustment Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Tandem Diabetics Automatic Insulin Dose Adjustment Software Product Portfolio Table 57. Tandem Diabetics Recent Development Table 58. CamDiab Company Information Table 59. CamDiab Business Overview Table 60. CamDiab Automatic Insulin Dose Adjustment Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. CamDiab Automatic Insulin Dose Adjustment Software Product Portfolio Table 62. CamDiab Recent Development Table 63. Medtronic Company Information Table 64. Medtronic Business Overview Table 65. Medtronic Automatic Insulin Dose Adjustment Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Medtronic Automatic Insulin Dose Adjustment Software Product Portfolio Table 67. Medtronic Recent Development Table 68. Novo Nordisk Company Information Table 69. Novo Nordisk Business Overview Table 70. Novo Nordisk Automatic Insulin Dose Adjustment Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Novo Nordisk Automatic Insulin Dose Adjustment Software Product Portfolio Table 72. Novo Nordisk Recent Development Table 73. Omnipod Company Information Table 74. Omnipod Business Overview Table 75. Omnipod Automatic Insulin Dose Adjustment Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Omnipod Automatic Insulin Dose Adjustment Software Product Portfolio Table 77. Omnipod Recent Development Table 78. Tempo Platform Company Information Table 79. Tempo Platform Business Overview Table 80. Tempo Platform Automatic Insulin Dose Adjustment Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Tempo Platform Automatic Insulin Dose Adjustment Software Product Portfolio Table 82. Tempo Platform Recent Development Table 83. Research Programs/Design for This Report Table 84. Authors List of This Report Table 85. Secondary Sources Table 86. Primary Sources List of Figures Figure 1. Automatic Insulin Dose Adjustment Software Product Image Figure 2. Global Automatic Insulin Dose Adjustment Software Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Automatic Insulin Dose Adjustment Software Market Size (2021-2032) & (US$ Million) Figure 4. Global Automatic Insulin Dose Adjustment Software Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Open-Loop Systems Image Figure 8. Closed-Loop Systems Image Figure 9. Global Automatic Insulin Dose Adjustment Software Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Automatic Insulin Dose Adjustment Software Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Automatic Insulin Dose Adjustment Software Sales Value Share by Type (2021-2032) Figure 12. Subscription Used Image Figure 13. One-time Purchase Used Image Figure 14. Global Automatic Insulin Dose Adjustment Software Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Automatic Insulin Dose Adjustment Software Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Automatic Insulin Dose Adjustment Software Sales Value Share by Application (2021-2032) Figure 17. Global Automatic Insulin Dose Adjustment Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Automatic Insulin Dose Adjustment Software Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America Automatic Insulin Dose Adjustment Software Sales Value (2021-2032) & (US$ Million) Figure 20. North America Automatic Insulin Dose Adjustment Software Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe Automatic Insulin Dose Adjustment Software Sales Value (2021-2032) & (US$ Million) Figure 22. Europe Automatic Insulin Dose Adjustment Software Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific Automatic Insulin Dose Adjustment Software Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific Automatic Insulin Dose Adjustment Software Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America Automatic Insulin Dose Adjustment Software Sales Value (2021-2032) & (US$ Million) Figure 26. South America Automatic Insulin Dose Adjustment Software Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa Automatic Insulin Dose Adjustment Software Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa Automatic Insulin Dose Adjustment Software Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA Automatic Insulin Dose Adjustment Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA Automatic Insulin Dose Adjustment Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA Automatic Insulin Dose Adjustment Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada Automatic Insulin Dose Adjustment Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada Automatic Insulin Dose Adjustment Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada Automatic Insulin Dose Adjustment Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico Automatic Insulin Dose Adjustment Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico Automatic Insulin Dose Adjustment Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico Automatic Insulin Dose Adjustment Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany Automatic Insulin Dose Adjustment Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany Automatic Insulin Dose Adjustment Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany Automatic Insulin Dose Adjustment Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France Automatic Insulin Dose Adjustment Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France Automatic Insulin Dose Adjustment Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France Automatic Insulin Dose Adjustment Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. Automatic Insulin Dose Adjustment Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. Automatic Insulin Dose Adjustment Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. Automatic Insulin Dose Adjustment Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy Automatic Insulin Dose Adjustment Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy Automatic Insulin Dose Adjustment Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy Automatic Insulin Dose Adjustment Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain Automatic Insulin Dose Adjustment Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain Automatic Insulin Dose Adjustment Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain Automatic Insulin Dose Adjustment Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia Automatic Insulin Dose Adjustment Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia Automatic Insulin Dose Adjustment Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia Automatic Insulin Dose Adjustment Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands Automatic Insulin Dose Adjustment Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands Automatic Insulin Dose Adjustment Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands Automatic Insulin Dose Adjustment Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries Automatic Insulin Dose Adjustment Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries Automatic Insulin Dose Adjustment Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries Automatic Insulin Dose Adjustment Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China Automatic Insulin Dose Adjustment Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China Automatic Insulin Dose Adjustment Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China Automatic Insulin Dose Adjustment Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan Automatic Insulin Dose Adjustment Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan Automatic Insulin Dose Adjustment Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan Automatic Insulin Dose Adjustment Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea Automatic Insulin Dose Adjustment Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea Automatic Insulin Dose Adjustment Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea Automatic Insulin Dose Adjustment Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India Automatic Insulin Dose Adjustment Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India Automatic Insulin Dose Adjustment Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India Automatic Insulin Dose Adjustment Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia Automatic Insulin Dose Adjustment Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia Automatic Insulin Dose Adjustment Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia Automatic Insulin Dose Adjustment Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia Automatic Insulin Dose Adjustment Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia Automatic Insulin Dose Adjustment Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia Automatic Insulin Dose Adjustment Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil Automatic Insulin Dose Adjustment Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil Automatic Insulin Dose Adjustment Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil Automatic Insulin Dose Adjustment Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina Automatic Insulin Dose Adjustment Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina Automatic Insulin Dose Adjustment Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina Automatic Insulin Dose Adjustment Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile Automatic Insulin Dose Adjustment Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile Automatic Insulin Dose Adjustment Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile Automatic Insulin Dose Adjustment Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia Automatic Insulin Dose Adjustment Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia Automatic Insulin Dose Adjustment Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia Automatic Insulin Dose Adjustment Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru Automatic Insulin Dose Adjustment Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru Automatic Insulin Dose Adjustment Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru Automatic Insulin Dose Adjustment Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia Automatic Insulin Dose Adjustment Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia Automatic Insulin Dose Adjustment Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Automatic Insulin Dose Adjustment Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel Automatic Insulin Dose Adjustment Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel Automatic Insulin Dose Adjustment Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel Automatic Insulin Dose Adjustment Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE Automatic Insulin Dose Adjustment Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE Automatic Insulin Dose Adjustment Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE Automatic Insulin Dose Adjustment Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey Automatic Insulin Dose Adjustment Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey Automatic Insulin Dose Adjustment Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey Automatic Insulin Dose Adjustment Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran Automatic Insulin Dose Adjustment Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran Automatic Insulin Dose Adjustment Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran Automatic Insulin Dose Adjustment Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt Automatic Insulin Dose Adjustment Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt Automatic Insulin Dose Adjustment Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt Automatic Insulin Dose Adjustment Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • Open-Loop Systems
  • Closed-Loop Systems
Applications
  • Subscription Used
  • One-time Purchase Used
Companies covered
  • Glytec
  • Beta Bionics
  • Hygieia
  • Tandem Diabetics
  • CamDiab
  • Medtronic
  • Novo Nordisk
  • Omnipod
  • Tempo Platform

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Automatic Insulin Dose Adjustment Software Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Automatic Insulin Dose Adjustment Software Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Automatic Insulin Dose Adjustment Software Market Dynamics
  1. 2.1 Automatic Insulin Dose Adjustment Software Industry Trends
  2. 2.2 Automatic Insulin Dose Adjustment Software Industry Drivers
  3. 2.3 Automatic Insulin Dose Adjustment Software Industry Opportunities and Challenges
  4. 2.4 Automatic Insulin Dose Adjustment Software Industry Restraints
3 Automatic Insulin Dose Adjustment Software Market by Company
  1. 3.1 Global Automatic Insulin Dose Adjustment Software Company Revenue Ranking in 2025
  2. 3.2 Global Automatic Insulin Dose Adjustment Software Revenue by Company (2021-2026)
  3. 3.3 Global Automatic Insulin Dose Adjustment Software Company Ranking (2024-2026)
  4. 3.4 Global Automatic Insulin Dose Adjustment Software Company Manufacturing Base and Headquarters
  5. 3.5 Global Automatic Insulin Dose Adjustment Software Company Product Type and Application
  6. 3.6 Global Automatic Insulin Dose Adjustment Software Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Automatic Insulin Dose Adjustment Software Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Automatic Insulin Dose Adjustment Software Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Automatic Insulin Dose Adjustment Software Market by Type
  1. 4.1 Automatic Insulin Dose Adjustment Software Type Introduction
  2. 4.1.1 Open-Loop Systems
  3. 4.1.2 Closed-Loop Systems
  4. 4.2 Global Automatic Insulin Dose Adjustment Software Sales Value by Type
  5. 4.2.1 Global Automatic Insulin Dose Adjustment Software Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Automatic Insulin Dose Adjustment Software Sales Value by Type (2021-2032)
  7. 4.2.3 Global Automatic Insulin Dose Adjustment Software Sales Value Share by Type (2021-2032)
5 Automatic Insulin Dose Adjustment Software Market by Application
  1. 5.1 Automatic Insulin Dose Adjustment Software Application Introduction
  2. 5.1.1 Subscription Used
  3. 5.1.2 One-time Purchase Used
  4. 5.2 Global Automatic Insulin Dose Adjustment Software Sales Value by Application
  5. 5.2.1 Global Automatic Insulin Dose Adjustment Software Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Automatic Insulin Dose Adjustment Software Sales Value by Application (2021-2032)
  7. 5.2.3 Global Automatic Insulin Dose Adjustment Software Sales Value Share by Application (2021-2032)
6 Automatic Insulin Dose Adjustment Software Regional Value Analysis
  1. 6.1 Global Automatic Insulin Dose Adjustment Software Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Automatic Insulin Dose Adjustment Software Sales Value by Region (2021-2032)
  3. 6.2.1 Global Automatic Insulin Dose Adjustment Software Sales Value by Region: 2021-2026
  4. 6.2.2 Global Automatic Insulin Dose Adjustment Software Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Automatic Insulin Dose Adjustment Software Sales Value (2021-2032)
  7. 6.3.2 North America Automatic Insulin Dose Adjustment Software Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Automatic Insulin Dose Adjustment Software Sales Value (2021-2032)
  10. 6.4.2 Europe Automatic Insulin Dose Adjustment Software Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Automatic Insulin Dose Adjustment Software Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Automatic Insulin Dose Adjustment Software Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Automatic Insulin Dose Adjustment Software Sales Value (2021-2032)
  16. 6.6.2 South America Automatic Insulin Dose Adjustment Software Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Automatic Insulin Dose Adjustment Software Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Automatic Insulin Dose Adjustment Software Sales Value Share by Country, 2025 VS 2032
7 Automatic Insulin Dose Adjustment Software Country-level Value Analysis
  1. 7.1 Global Automatic Insulin Dose Adjustment Software Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Automatic Insulin Dose Adjustment Software Sales Value by Country (2021-2032)
  3. 7.2.1 Global Automatic Insulin Dose Adjustment Software Sales Value by Country (2021-2026)
  4. 7.2.2 Global Automatic Insulin Dose Adjustment Software Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Automatic Insulin Dose Adjustment Software Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Automatic Insulin Dose Adjustment Software Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Automatic Insulin Dose Adjustment Software Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Automatic Insulin Dose Adjustment Software Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Automatic Insulin Dose Adjustment Software Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Automatic Insulin Dose Adjustment Software Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Automatic Insulin Dose Adjustment Software Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Automatic Insulin Dose Adjustment Software Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Automatic Insulin Dose Adjustment Software Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Automatic Insulin Dose Adjustment Software Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Automatic Insulin Dose Adjustment Software Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Automatic Insulin Dose Adjustment Software Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Automatic Insulin Dose Adjustment Software Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Automatic Insulin Dose Adjustment Software Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Automatic Insulin Dose Adjustment Software Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Automatic Insulin Dose Adjustment Software Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Automatic Insulin Dose Adjustment Software Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Automatic Insulin Dose Adjustment Software Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Automatic Insulin Dose Adjustment Software Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Automatic Insulin Dose Adjustment Software Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Automatic Insulin Dose Adjustment Software Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Automatic Insulin Dose Adjustment Software Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Automatic Insulin Dose Adjustment Software Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Automatic Insulin Dose Adjustment Software Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Automatic Insulin Dose Adjustment Software Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Automatic Insulin Dose Adjustment Software Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Automatic Insulin Dose Adjustment Software Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Automatic Insulin Dose Adjustment Software Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Automatic Insulin Dose Adjustment Software Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Automatic Insulin Dose Adjustment Software Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Automatic Insulin Dose Adjustment Software Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Automatic Insulin Dose Adjustment Software Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Automatic Insulin Dose Adjustment Software Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Automatic Insulin Dose Adjustment Software Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Automatic Insulin Dose Adjustment Software Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Automatic Insulin Dose Adjustment Software Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Automatic Insulin Dose Adjustment Software Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Automatic Insulin Dose Adjustment Software Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Automatic Insulin Dose Adjustment Software Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Automatic Insulin Dose Adjustment Software Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Automatic Insulin Dose Adjustment Software Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Automatic Insulin Dose Adjustment Software Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Automatic Insulin Dose Adjustment Software Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Automatic Insulin Dose Adjustment Software Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Automatic Insulin Dose Adjustment Software Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Automatic Insulin Dose Adjustment Software Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Automatic Insulin Dose Adjustment Software Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Automatic Insulin Dose Adjustment Software Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Automatic Insulin Dose Adjustment Software Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Automatic Insulin Dose Adjustment Software Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Automatic Insulin Dose Adjustment Software Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Automatic Insulin Dose Adjustment Software Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Automatic Insulin Dose Adjustment Software Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Automatic Insulin Dose Adjustment Software Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Automatic Insulin Dose Adjustment Software Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Automatic Insulin Dose Adjustment Software Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Automatic Insulin Dose Adjustment Software Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Automatic Insulin Dose Adjustment Software Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Automatic Insulin Dose Adjustment Software Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Automatic Insulin Dose Adjustment Software Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Automatic Insulin Dose Adjustment Software Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Automatic Insulin Dose Adjustment Software Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Automatic Insulin Dose Adjustment Software Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Automatic Insulin Dose Adjustment Software Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Automatic Insulin Dose Adjustment Software Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Automatic Insulin Dose Adjustment Software Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Automatic Insulin Dose Adjustment Software Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Automatic Insulin Dose Adjustment Software Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Automatic Insulin Dose Adjustment Software Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Automatic Insulin Dose Adjustment Software Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Automatic Insulin Dose Adjustment Software Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Automatic Insulin Dose Adjustment Software Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Automatic Insulin Dose Adjustment Software Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Automatic Insulin Dose Adjustment Software Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Automatic Insulin Dose Adjustment Software Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Automatic Insulin Dose Adjustment Software Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Automatic Insulin Dose Adjustment Software Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Automatic Insulin Dose Adjustment Software Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Automatic Insulin Dose Adjustment Software Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Automatic Insulin Dose Adjustment Software Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Automatic Insulin Dose Adjustment Software Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Automatic Insulin Dose Adjustment Software Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Automatic Insulin Dose Adjustment Software Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Automatic Insulin Dose Adjustment Software Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Glytec
  2. 8.1.1 Glytec Company Information
  3. 8.1.2 Glytec Business Overview
  4. 8.1.3 Glytec Automatic Insulin Dose Adjustment Software Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Glytec Automatic Insulin Dose Adjustment Software Product Portfolio
  6. 8.1.5 Glytec Recent Developments
  7. 8.2 Beta Bionics
  8. 8.2.1 Beta Bionics Company Information
  9. 8.2.2 Beta Bionics Business Overview
  10. 8.2.3 Beta Bionics Automatic Insulin Dose Adjustment Software Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Beta Bionics Automatic Insulin Dose Adjustment Software Product Portfolio
  12. 8.2.5 Beta Bionics Recent Developments
  13. 8.3 Hygieia
  14. 8.3.1 Hygieia Company Information
  15. 8.3.2 Hygieia Business Overview
  16. 8.3.3 Hygieia Automatic Insulin Dose Adjustment Software Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Hygieia Automatic Insulin Dose Adjustment Software Product Portfolio
  18. 8.3.5 Hygieia Recent Developments
  19. 8.4 Tandem Diabetics
  20. 8.4.1 Tandem Diabetics Company Information
  21. 8.4.2 Tandem Diabetics Business Overview
  22. 8.4.3 Tandem Diabetics Automatic Insulin Dose Adjustment Software Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Tandem Diabetics Automatic Insulin Dose Adjustment Software Product Portfolio
  24. 8.4.5 Tandem Diabetics Recent Developments
  25. 8.5 CamDiab
  26. 8.5.1 CamDiab Company Information
  27. 8.5.2 CamDiab Business Overview
  28. 8.5.3 CamDiab Automatic Insulin Dose Adjustment Software Revenue and Gross Margin (2021-2026)
  29. 8.5.4 CamDiab Automatic Insulin Dose Adjustment Software Product Portfolio
  30. 8.5.5 CamDiab Recent Developments
  31. 8.6 Medtronic
  32. 8.6.1 Medtronic Company Information
  33. 8.6.2 Medtronic Business Overview
  34. 8.6.3 Medtronic Automatic Insulin Dose Adjustment Software Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Medtronic Automatic Insulin Dose Adjustment Software Product Portfolio
  36. 8.6.5 Medtronic Recent Developments
  37. 8.7 Novo Nordisk
  38. 8.7.1 Novo Nordisk Company Information
  39. 8.7.2 Novo Nordisk Business Overview
  40. 8.7.3 Novo Nordisk Automatic Insulin Dose Adjustment Software Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Novo Nordisk Automatic Insulin Dose Adjustment Software Product Portfolio
  42. 8.7.5 Novo Nordisk Recent Developments
  43. 8.8 Omnipod
  44. 8.8.1 Omnipod Company Information
  45. 8.8.2 Omnipod Business Overview
  46. 8.8.3 Omnipod Automatic Insulin Dose Adjustment Software Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Omnipod Automatic Insulin Dose Adjustment Software Product Portfolio
  48. 8.8.5 Omnipod Recent Developments
  49. 8.9 Tempo Platform
  50. 8.9.1 Tempo Platform Company Information
  51. 8.9.2 Tempo Platform Business Overview
  52. 8.9.3 Tempo Platform Automatic Insulin Dose Adjustment Software Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Tempo Platform Automatic Insulin Dose Adjustment Software Product Portfolio
  54. 8.9.5 Tempo Platform Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst